disclosures
play

Disclosures Arrhythmogenic Right Ventricular Cardiomyopathy: Abbott - PDF document

9/14/2019 Disclosures Arrhythmogenic Right Ventricular Cardiomyopathy: Abbott Labs: Grant support Diagnosis Harikrishna Tandri Associate Professor of Medicine Director of VT Ablation Johns Hopkins Medical Institutions www.ARVD.com


  1. 9/14/2019 Disclosures Arrhythmogenic Right Ventricular Cardiomyopathy: • Abbott Labs: Grant support Diagnosis Harikrishna Tandri Associate Professor of Medicine Director of VT Ablation Johns Hopkins Medical Institutions www.ARVD.com Arrhythmogenic Right Ventricular Objectives Dysplasia/Cardiomyopathy • Provide overview of ARVC clinical • Familial cardiomyopathy presentation and diagnosis – Fibro-fatty infiltration of the • Describe the role of task force criteria RV – RV dysfunction • Describe MRI features of ARVC – Ventricular arrhythmias • Role of electroanatomic mapping • Concept of Arrhythmogenic • 1 in 5000 individuals Cardiomyopathy (Italy) 1

  2. 9/14/2019 Classic ARVC Is a Desmosomal Establishing an Accurate Myopathy Diagnosis • Comprehensive evaluation including history, family history, exercise history, physical exam, ECG, SAECG, Holter, Echo, MRI, and stress test • Genetic testing when the diagnosis is suspected • Application of the 2010 Task Force Criteria Figure 4. Approach to understand Figure 4. Approach to understanding the common pathway and genetic variants in a patient with 2010 ARVD Diagnostic Criteria Parameter 1994 Criteria 2010 Criteria RV Size and Function Non quantitative Quantitative Biopsy (major) Fibrofatty replacement < 60% nl myocytes & fibrous replacement +/- fat T wave inversion v2 Minor criteria in absence Major criteria in absence of RBBB and V3 RBBB QRS > 120 msec Minor: T wave inv V1, V2 or in V4,V5, and V6 or T in V1-v4 w RBBB Epsilon waves (major) Epsilon or localized Epsilon waves prolongation > 110 ms V1-V3 SAECG (minor) Late potentials Quantitative, 1 of 3 parameters TAD NA >= 55 msec in V1-v3 LBBB VT (minor) Minor criteria Major criteria if LB sup axis VT, European Heart J 2010; 31: 806-814. minor criteria if not Circ 2010; 121; 1533-41 Frequent PVCs (minor) > 1000/ 24 hrs > 500 / 24 hrs Family History (Major) Familial disease confirmed by ARVD in first degree relative OR autopsy or surgery pathogenic mutation in patient Family History (Minor) FH of premature SCD < 35 FH of ARVD where task force criteria yrs or family hx of ARVD unclear or premature SD < 35 yrs 2

  3. 9/14/2019 ARVD Diagnostic Criteria ฀ – – ECG Features of ARVD Parameter 1994 Criteria 2010 Criteria RV Size and Function Non quantitative Quantitative Biopsy (major) Fibrofatty replacement < 60% nl myocytes & fibrous replacement +/- fat “ ” T wave inversion v2 Minor criteria in absence Major criteria in absence of RBBB and V3 RBBB QRS > 120 msec Minor: T wave inv V1, V2 or in V4,V5, and V6 or T in V1-v4 w RBBB Epsilon waves (major) Epsilon or localized Epsilon waves prolongation > 110 ms V1-V3 SAECG (minor) Late potentials Quantitative, 1 of 3 parameters ฀ – TAD NA >= 55 msec in V1-v3 LBBB VT (minor) Minor criteria Major criteria if LB sup axis VT, minor criteria if not Frequent PVCs (minor) > 1000/ 24 hrs > 500 / 24 hrs Family History (Major) Familial disease confirmed by ARVD in first degree relative OR autopsy or surgery pathogenic mutation in patient Family History (Minor) FH of premature SCD < 35 FH of ARVD where task force criteria yrs or family hx of ARVD unclear or premature SD < 35 yrs Structural abnormalities in Arrhythmias in ARVC ARVD/C • High burden of PVCs • CMR is the modality of choice for RV evaluation • NSVT of LBBB morphology • May be unifocal or multifocal • Provides tissue characterization (Fat and fibrosis • Catecholamine sensitive imaging) • PVC count is both diagnostic and prognostic • RV quantitative functional assessment 3

  4. 9/14/2019 Advanced Fat detection: ARVD/C • Path RV RV LV RA • MRI RV Castillo et al, Radiology, 2004 ARVD/C ARVD RV RV LV RA LV RA 4

  5. 9/14/2019 Example of LV fat LV involvement in classic ARVC • Unrelated to RV disease • Prevalence about 25% • Usually asymptomatic • LV failure rare • Typically affects postero-lateral and inferior basal LV Fat in ARVD/C Regional dysfunction in ARVD/C • Not sensitive to the disease • More sensitive than fat (85% vs 68%) • Limited diagnostic value as a stand alone criteria • Earliest phenotypic expression of ARVD/C • Often associated with wall motion abnormality in ARVD • More reproducible compared to fat • Fat in the RV can be see in obesity and old infiltration*. age * Bomma C et al, J Cardiovasc Electrophysiol. 2004. 5

  6. 9/14/2019 MR Findings in early ARVD/C • Regional dysfunction limited to sub- tricuspid and RV OT • Best seen in axial cine and four chamber images Regional wall motion assessment Biventricular ARVC • Four chamber and axial images are optimal • Acute angle of the RV and the RV out flow are the regions of interest. 6

  7. 9/14/2019 Delayed Enhancement in ARVD/C Delayed enhancement in ARVD/C • PSIR sequence is preferred • Often diffuse and associated with RV dysfunction • Useful in differential diagnosis Diagnostic Value of Isoproterenol Testing in High dose catecholamine infusion ARVC 45 mcg/min for 3 minutes • Continuous infusion of isoproterenol (45 μ g/min) for 3 Complex Ventricular Ectopy I II minutes II I aVR • Polymorphic PVCs or NSVT in 32 of 35 (91.4%) aVL aVF patients with ARVC vs. 42 of 377 (11.1%) of non V1 ARVC V2 V3 • Sensitivity and specificity for ARVC were 91.4%, V4 V5 V6 88.9% respectively Denis A et al Circ Arrhythm Electrophysiol . 2014;7:590-597. 7

  8. 9/14/2019 Patterns of Epicardial Scar in ARVD/C Electroanatomic Substrate Classic ARVC patient • Athletic male or female • Age between 16-40 (mean 32 yrs.) • Family history of CM or SCD • Palpitations, post exertional syncope • T wave inversions beyond V3 • High PVC burden RV APEX IS NOT A FREQUENT SITE FOR • RV basal dyskinesis on CMR VT 8

  9. 9/14/2019 Less common presentations Clinical Assessment • Myocarditis with RV regional dysfunction • ECG, Holter, echocardiogram • PVCs during routine exam with abnormal • CMR 12 lead • EP study with mapping in difficult cases • VT/PVCs with LV basal epicardial • If diagnosis suspected - genetic counseling enhancement (DSP) • Follow up with Holter and echocardiogram • Dilated CM with high PVC burden (PLN/DSP) Arrhythmogenic Cardiomyopathies Genetic ACM (ACM) • Group of CM with high burden of arrhythmias and overlapping clinical presentations • ARVC is categorized as genetic ACM • Also includes Sarcoid, Amyloid and Chagasic CM 9

  10. 9/14/2019 Conclusions • ARVD/C is a highly arrhythmic genetic cardiomyopathy • Classic ARVC affects RV sub-tricuspid region • ALVC affects the epicardial LV and overlaps with dilated cardiomyopathy • RV arrhythmias are common in both ARVC and ALVC • Myocarditis and LV dysfunction can be presenting features • Diagnosis should be based on meeting the task force criteria (No single test is diagnostic) 10

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend